title: [Raynaud's phenomenon secondary to anti-glaucoma eye drops].
authors.affiliation: Unidad de Asesoramiento Científico-técnico, avalia-t, Axencia de Coñecemento en Saúde (ACIS), Servicio Gallego de Salud, Santiago de Compostela, España. Electronic address: rosendo.bugarin.gonzalez@sergas.es.
authors.forename: R
authors.initials: R
authors.lastname: Bugarín-González
authors.affiliation: Estrutura Organizativa de Xestión Integrada (EOXI) de Santiago de Compostela, Servicio Gallego de Salud, Santiago de Compostela, A Coruña, España.
authors.forename: M
authors.initials: M
authors.lastname: Portela-Romero
authors.affiliation: Unidad de Asesoramiento Científico-técnico, avalia-t, Axencia de Coñecemento en Saúde (ACIS), Servicio Gallego de Salud, Santiago de Compostela, España.
authors.forename: M C
authors.initials: MC
authors.lastname: Maceira-Rozas
authors.affiliation: Consellería de Sanidad, Xunta de Galicia, Santiago de Compostela, España.
authors.forename: P
authors.initials: P
authors.lastname: López-Vázquez
authors.affiliation: King's College, Londres, Reino Unido.
authors.forename: C
authors.initials: C
authors.lastname: Bugarín-Diz
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects; D004338:Drug Combinations; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D008297:Male; D009883:Ophthalmic Solutions; D011928:Raynaud Disease / Q000139:chemically induced* / Q000175:diagnosis; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects*; D013876:Thiophenes / Q000008:administration & dosage / Q000009:adverse effects*; D013999:Timolol / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000959:Antihypertensive Agents; D004338:Drug Combinations; D009883:Ophthalmic Solutions; D013449:Sulfonamides; D013876:Thiophenes; C479140:dorzolamide-timolol combination; D013999:Timolol